ATLASTelomir Pharmaceuticals (TELO) earnings date: Nov 9, 2026
Telomir Pharmaceuticals (TELO) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TELO
| Last price | $0.93 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.6% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Telomir Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Telomir Pharmaceuticals reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Telomir Pharmaceuticals. You can switch it off at any time.
Alert me before TELO reportsFree to start. Creating an account takes under a minute.
Notify me when Telomir Pharmaceuticals reports
Track TELO free Add Telomir Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
TELO earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 8, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +39.4% |
| Average move around a report | ±3.3% (last 4) |
| Sector | Healthcare · Biotechnology |
Telomir Pharmaceuticals earnings history: last 4 reports
Telomir Pharmaceuticals last reported on Aug 8, 2026: EPS of $6.03 against an estimate of $5.13 (+17.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 8, 2026 | $5.13 | $6.03 | +17.5% | Beat | -2.6% |
| May 13, 2026 | $0.03 | $0.05 | +66.7% | Beat | +0.8% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -1.5% |
| Nov 10, 2025 | -$0.07 | -$0.03 | +57.1% | Beat | +8.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TELO
See the fair value, the probability range and the earnings history of Telomir Pharmaceuticals on its ATLAS page.
Telomir Pharmaceuticals (TELO) stock analysisPlans from €3.99 a month.
Telomir Pharmaceuticals earnings: frequently asked questions
When does Telomir Pharmaceuticals (TELO) report earnings?
Telomir Pharmaceuticals is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does TELO beat earnings estimates?
Of its last 4 reports with a recorded result, Telomir Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +39.4%. Past results do not predict the next one.
How much does TELO move around earnings?
Over its last 4 reports the stock moved an average of 3.3% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Telomir Pharmaceuticals beat earnings estimates last quarter?
Telomir Pharmaceuticals last reported on Aug 8, 2026: EPS of $6.03 against an estimate of $5.13 (+17.5% surprise), a beat.
How much does TELO usually move in a day?
On a normal trading day the ATLAS model puts TELO’s one-day range at about ±3.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer